| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2008-09-25 13:33:51 UTC |
|---|
| Update Date | 2022-03-07 02:50:59 UTC |
|---|
| HMDB ID | HMDB0010575 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | PG(16:0/18:2(9Z,12Z)) |
|---|
| Description | PG(16:0/18:2(9Z,12Z)) is a phosphatidylglycerol or glycerophospholipid (PG or GP). It is a glycerophospholipid in which a phosphoglycerol moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PG(16:0/18:2(9Z,12Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of linoleic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the linoleic acid moiety is derived from seed oils. Phosphatidylglycerol is present at a level of 1-2% in most animal tissues, but it can be the second most abundant phospholipid in lung surfactant at up to 11% of the total. It is well established that the concentration of phosphatidylglycerol increases during fetal development. Phosphatidylglycerol may be present in animal tissues merely as a precursor for diphosphatidylglycerol (cardiolipin). Phosphatidylglycerol is formed from phosphatidic acid by a sequence of enzymatic reactions that proceeds via the intermediate, cytidine diphosphate diacylglycerol (CDP-diacylglycerol). Bioynthesis proceeds by condensation of phosphatidic acid and cytidine triphosphate with elimination of pyrophosphate via the action of phosphatidate cytidyltransferase (or CDP-synthase). CDP-diacylglycerol then reacts with glycerol-3-phosphate via phosphatidylglycerophosphate synthase to form 3-sn-phosphatidyl-1'-sn-glycerol 3'-phosphoric acid, with the release of cytidine monophosphate (CMP). Finally, phosphatidylglycerol is formed by the action of specific phosphatases. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PGs have a net charge of -1 at physiological pH and are found in high concentration in mitochondrial membranes and as components of pulmonary surfactant. PG also serves as a precursor for the synthesis of cardiolipin. PG is synthesized from CDP-diacylglycerol and glycerol-3-phosphate. |
|---|
| Structure | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC InChI=1S/C40H75O10P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-40(44)50-38(36-49-51(45,46)48-34-37(42)33-41)35-47-39(43)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h11,13,17-18,37-38,41-42H,3-10,12,14-16,19-36H2,1-2H3,(H,45,46)/b13-11-,18-17-/t37-,38+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Palmitoyl-2-linoleoyl-sn-glycero-3-phosphoglycerol | ChEBI | | 2-Linoleoyl-1-palmitoyl-sn-glycero-3-phospho-(1'-sn-glycerol) | ChEBI | | GPG(16:0/18:2) | ChEBI | | GPG(16:0/18:2OMEGA6) | ChEBI | | GPG(34:2) | ChEBI | | PG(16:0/18:2) | ChEBI | | PG(16:0/18:2OMEGA6) | ChEBI | | PG(34:2) | ChEBI | | Phosphatidylglycerol(16:0/18:2) | ChEBI | | Phosphatidylglycerol(16:0/18:2omega6) | ChEBI | | Phosphatidylglycerol(34:2) | ChEBI | | 1-Hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-(1'-glycerol) | HMDB | | GPG(16:0/18:2N6) | HMDB | | GPG(16:0/18:2W6) | HMDB | | PG(16:0/18:2N6) | HMDB | | PG(16:0/18:2W6) | HMDB | | Phosphatidylglycerol(16:0/18:2n6) | HMDB | | Phosphatidylglycerol(16:0/18:2W6) | HMDB | | 1-Hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphoglycerol | HMDB | | PG(16:0/18:2(9Z,12Z)) | Lipid Annotator |
|
|---|
| Chemical Formula | C40H75O10P |
|---|
| Average Molecular Weight | 746.9913 |
|---|
| Monoisotopic Molecular Weight | 746.509785132 |
|---|
| IUPAC Name | [(2S)-2,3-dihydroxypropoxy][(2R)-3-(hexadecanoyloxy)-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy]phosphinic acid |
|---|
| Traditional Name | (2S)-2,3-dihydroxypropoxy(2R)-3-(hexadecanoyloxy)-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxyphosphinic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@](O)(CO)COP(O)(=O)OC[C@@]([H])(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC |
|---|
| InChI Identifier | InChI=1S/C40H75O10P/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-40(44)50-38(36-49-51(45,46)48-34-37(42)33-41)35-47-39(43)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h11,13,17-18,37-38,41-42H,3-10,12,14-16,19-36H2,1-2H3,(H,45,46)/b13-11-,18-17-/t37-,38+/m0/s1 |
|---|
| InChI Key | ATBOMIWRCZXYSZ-WLGRLVTESA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phosphatidylglycerols. These are glycerophosphoglycerols in which two fatty acids are bonded to the 1-glycerol moiety through ester linkages. As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphoglycerols |
|---|
| Direct Parent | Phosphatidylglycerols |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-diacylglycerophosphoglycerol
- Fatty acid ester
- Dialkyl phosphate
- Dicarboxylic acid or derivatives
- Organic phosphoric acid derivative
- Phosphoric acid ester
- Alkyl phosphate
- Fatty acyl
- 1,2-diol
- Carboxylic acid ester
- Secondary alcohol
- Carboxylic acid derivative
- Organic oxide
- Organooxygen compound
- Alcohol
- Organic oxygen compound
- Primary alcohol
- Carbonyl group
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/16:1(9Z)) (PathBank: SMP0077478)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0068713)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/16:1(9Z)/16:0) (PathBank: SMP0068715)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:0/16:0) (PathBank: SMP0068718)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:0/18:0) (PathBank: SMP0068719)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/18:0) (PathBank: SMP0068731)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(11Z)) (PathBank: SMP0068732)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0068736)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0068737)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0068738)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0068741)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0068744)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:1(11Z)/18:1(9Z)) (PathBank: SMP0077471)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:1(9Z)/18:1(11Z)) (PathBank: SMP0077474)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/16:0) (PathBank: SMP0077487)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/18:2(9Z,12Z)) (PathBank: SMP0077491)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)) (PathBank: SMP0077495)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)) (PathBank: SMP0083753)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0083762)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/20:0) (PathBank: SMP0083764)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/16:1(9Z)/16:1(9Z)) (PathBank: SMP0092737)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:1(11Z)/18:1(11Z)) (PathBank: SMP0092743)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/16:0) (PathBank: SMP0092750)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0092756)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/16:0) (PathBank: SMP0092767)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:2(9Z,12Z)) (PathBank: SMP0092772)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0098560)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/20:0) (PathBank: SMP0098561)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0098564)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0098567)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/22:0) (PathBank: SMP0098572)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/22:1(13Z)) (PathBank: SMP0098573)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:0/20:0) (PathBank: SMP0098574)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:0/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0098577)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:0/22:0) (PathBank: SMP0098578)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:1(11Z)/22:0) (PathBank: SMP0098583)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:1(11Z)/22:1(13Z)) (PathBank: SMP0098584)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0068714)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:1(11Z)/16:0) (PathBank: SMP0068721)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/16:0) (PathBank: SMP0068742)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0068745)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0068748)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0068752)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:1(9Z)/16:0) (PathBank: SMP0077473)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0) (PathBank: SMP0077498)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0083754)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0092733)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/16:1(9Z)/18:2(9Z,12Z)) (PathBank: SMP0092738)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/18:1(9Z)) (PathBank: SMP0092754)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)) (PathBank: SMP0092761)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/20:1(11Z)) (PathBank: SMP0098569)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:1(11Z)/20:1(11Z)) (PathBank: SMP0098580)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/22:1(13Z)/22:1(13Z)) (PathBank: SMP0098594)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/16:0/18:2(9Z,12Z)) (PathBank: SMP0068710)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:0/18:2(9Z,12Z)) (PathBank: SMP0068720)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:1(9Z)/18:2(9Z,12Z)) (PathBank: SMP0068728)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:1(9Z)/18:1(9Z)) (PathBank: SMP0077475)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0092770)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/20:1(11Z)) (PathBank: SMP0098562)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/20:0) (PathBank: SMP0098568)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0098571)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:0/22:1(13Z)) (PathBank: SMP0098579)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0098586)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0098589)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/16:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0068711)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:1(11Z)/18:2(9Z,12Z)) (PathBank: SMP0068724)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0083763)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/22:0) (PathBank: SMP0098565)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/22:1(13Z)) (PathBank: SMP0098566)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0098570)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:0/20:1(11Z)) (PathBank: SMP0098575)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0098576)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/22:0/22:0) (PathBank: SMP0098592)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/22:0/22:1(13Z)) (PathBank: SMP0098593)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/20:1(13Z)) (PathBank: SMP0081116)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/20:1(11Z)) (PathBank: SMP0081122)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/20:1(13Z)) (PathBank: SMP0081123)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/22:0) (PathBank: SMP0081124)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/22:1(13Z)) (PathBank: SMP0081125)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/20:1(13Z)) (PathBank: SMP0081129)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:0/20:1(13Z)) (PathBank: SMP0081134)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:1(11Z)/20:1(13Z)) (PathBank: SMP0081138)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:1(13Z)/20:1(13Z)) (PathBank: SMP0081141)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:1(13Z)/22:0) (PathBank: SMP0081142)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:1(13Z)/22:1(13Z)) (PathBank: SMP0081143)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0083757)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0083758)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083761)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0083765)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0083766)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083767)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083768)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(6Z,9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083769)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0083772)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0083773)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083776)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:0/20:3(5Z,8Z,11Z)) (PathBank: SMP0083778)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:0/20:3(8Z,11Z,14Z)) (PathBank: SMP0083779)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:0/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083782)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0083783)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0083784)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083785)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083786)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:3(5Z,8Z,11Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083787)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0083788)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:3(8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0083789)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:3(8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0083790)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:3(8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083791)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083794)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083796)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083797)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:1(11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0098581)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:1(11Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0098582)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/22:0) (PathBank: SMP0098587)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)/22:1(13Z)) (PathBank: SMP0098588)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/22:0) (PathBank: SMP0098590)
- Cardiolipin Biosynthesis CL(16:0/18:2(9Z,12Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z)) (PathBank: SMP0098591)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 9.49 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 29.4259 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.0 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 81.2 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 5301.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 313.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 325.7 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 200.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1064.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1633.5 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1184.9 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 245.8 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3062.7 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1100.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2785.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1209.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 693.4 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 384.9 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 563.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized |
|---|